Homeland Security News Wire

  • Home
  • About us
  • Subscribe
  • Advertise
  • Contact
  • RSS Feed
Home

Research and Development

  • BIOMETRICS
  • Border/Immig.
  • Business
  • Cybersecurity
  • Detection
  • Disasters
  • Government
  • Infrastructure
  • Public Safety
  • Public health
  • Regional
  • Sci-Tech
  • Surveillance
  • Terrorism
  • Transportation
  • Water

  • A Coronavirus Vaccine Is Still Months Away, but an Antibody Treatment Could Be Closer

    Vaccines have gotten all the attention in the race to fight Covid-19, but there is a major push in the United States to develop antibody therapies to treat coronavirus. Jen Christensen writes for CNN that there’s so much of a push that some scientists think these treatments may be available this year, even before a vaccine.

  • Controversy on COVID-19 Mask Study Spotlights Messiness of Science during a Pandemic

    Late last week, a group of researchers posted a letter that they had sent to the Proceedings of National Academy of Sciences (PNAS) requesting the retraction of a study published the week before that purportedly showed mask use was the most effective intervention in slowing the spread of COVID-19 in New York City. Stephanie Soucheray writes for CIDRAP that though PNAS editors have yet to respond to the request, scientists have roundly criticized the study’s methodology, and the entire kerfuffle has highlighted the difficulty of “doing science” amid a full-blown pandemic.

  • Common Drug Reduces Coronavirus Deaths, Scientists Report

    In an unexpected glimmer of hope amid an expanding pandemic, scientists at the University of Oxford said on Tuesday that an inexpensive and commonly available drug reduced deaths in patients with severe Covid-19, the illness caused by the coronavirus. Benjamin Mueller and Roni Caryn Rabin write in the New York Times that if the finding is borne out, the drug, a steroid called dexamethasone, would be the first treatment shown to reduce mortality in the sickest patients and may save hundreds of thousands of lives, eventually even millions, altering the course of the pandemic.

  • How Antibodies from Llamas May Lead to COVID-19 Treatment

    Scientists hope the special antibodies that llamas make can be directed against SARS-CoV-2 to help find our way out of the pandemic. Rockefeller University says that humans, too, make antibodies against SARS-CoV-2, and many groups are working on developing treatments based on them. Llama antibodies, however, come in a simpler design than their human counterparts. “For reasons that we don’t really understand, these animals make this variant of antibody that just has fantastic properties,” says Michael P. Rout, a structural biologist at Rockefeller. “It contains the good disease-recognizing parts of a human antibody, packed into a condensed warhead.”

  • Research Integrity: Why We Should Trust Registered Clinical Trials

    In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

    • Read more
  • Breakthrough for Foot-and-Mouth Disease Vaccine

    When it comes to livestock, foot-and-mouth disease (FMD) is probably the most devastating picornavirus on the planet. FMD is a serious and economically devastating livestock disease. Foot-and-mouth disease virus (FMDV), the virus causing FMD, is extremely contagious and afflicts animals with cloven hooves like cows, pigs, sheep and deer.

    • Read more
  • Scientists Aim Gene-Targeting Breakthrough against COVID-19

    A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19, the Berkeley Labreports.

  • New Identification of Genetic Basis of COVID-19 Susceptibility Will Aid Treatment and Prevention

    The clinical presentation of COVID-19 varies from patient to patient and understanding individual genetic susceptibility to the disease is therefore vital to prognosis, prevention, and the development of new treatments. The European Society of Human Genetics reports that for the first time, Italian scientists have been able to identify the genetic and molecular basis of this susceptibility to infection as well as to the possibility of contracting a more severe form of the disease.

  • Majority of First-Wave COVID-19 Clinical Trials Have Significant Design Shortcomings, Study Finds

    Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

  • Asymptomatic Spread of Coronavirus is “Very Rare,” WHO Says

    Coronavirus patients without symptoms aren’t driving the spread of the virus, World Health Organization officials said Monday, casting doubt on concerns by some researchers that the disease could be difficult to contain due to asymptomatic infections, CNBC reports.

  • Was COVID-19 Created in a Lab? China Has Some Urgent Questions to Answer

    In an interview with  The Telegraph’s Allison Pearsonon Thursday, Sir Richard Dearlove, the former head of MI6, said it was likely that coronavirus was the result of a Chinese lab accidental release. Charles Moore writes in The Telegraph that Sir Richard’s interview chiefly concerned a new learned paper about the hunt for a COVID-19 vaccine, written by distinguished scientists, the vaccinologist, Birger Sorensen, and the immunologist, Angus Dalgleish, in the Quarterly Review of Biophysics Discovery.

  • Oxford Vaccine Team Chases Coronavirus to Brazil

    Oxford University’s potential Covid-19 vaccine will be tested in Brazil as scientists rush to find places with high enough rates of infection to determine whether their inoculations work. Rhys Blakely and Catherine Philp write in The Times that Astrazeneca, the drugmaker partnering with the university, said that finding communities with sufficient virus transmission to prove that a vaccine offered protection was now the toughest challenge in the race to develop a jab.

  • China Formulates Plan to Roll Out Vaccine before Clinical Trials Are Finished in Race against Trump

    China has five vaccines in phase II human trials – more than any other country, and it may deploy one or more of them as early as September to at-risk groups even if clinical trials have yet to be completed, Sophia Yan writes in The Telegraph. Success could buoy China’s coronavirus-ravaged economy, help Beijing deflect global anger over its cover-up of the pandemic – and it would also be a blow to Donald Trump’s “warp-speed” plans for a vaccine.

  • GCHQ Boss Warns Foreign States Are Trying to Steal Britain’s Attempts to Build COVID-19 Vaccine

    Jeremy Fleming, the Director of GCHQ, Britain’s cyberspy agency, confirmed GCHQ had seen attacks on the U.K.’s health infrastructure in recent weeks. Dominic Nicholls writes in The Telegraph that Fleming confirmed reports that foreign powers and criminals are targeting laboratories researching coronavirus vaccines.

  • Could Coronavirus Be Killed Off Without a Vaccine? History Suggests There's a Chance

    Already this century, devastating outbreaks of deadly cousins of today’s virus have twice been crushed without global immunization programs – the 2002-2003 SARS-COV-1 and the 2014-2015 Ebola. Harry de Quetteville asks in The Telegraph: as countries around the world begin to relax their lockdowns, will the third time be lucky too?

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

More headlines

  • S&T Needs to Improve Its Management and Oversight of R&D Projects
  • NSA's cyber wing looks to safeguard COVID research and expand outreach
  • China’s Breeding Giant Pigs That Are as Heavy as Polar Bears
  • Elon Musk is once again on a quest to ‘nuke Mars’
  • Experimental botulism antitoxin safe, effective in adults, study finds
  • ‘The Chinese have already broken into my stuff’: Cyber espionage concerns Army acquisition three-star https://www.armytimes.com/news/your-army/2019/07/16/the-chinese-have-already-broken-into-my-stuff-cyber-espionage-concerns-army-acquisition-three-star/
  • DHS Research Wing Remains Vulnerable to Insider Threats
  • Smuggling of US tech said to be outpacing Cold War levels
  • White House Opens Applications for Technology Modernization Fund
  • Trump 2019 Budget Boosts Cyber Spending But Cuts Research
  • Nuclear reactor restarts, but Japan’s energy policy in flux
  • Hawking says he lost $100 bet over Higgs discovery
  • Kansas getting $500K in law enforcement grants
  • Bill widens Sacramento police, sheriff’s contract security opportunities
  • DHS awards $97 million in port security grants
  • DHS awarding $1.3 billion in 2012 preparedness grants
  • Cellphone firms share location data with law enforcement, not users
  • Residents of Murrieta, California, will have to subscribe for emergency services
  • Ohio’s Homeland Security funding drops sharply
  • Ports of L.A., Long Beach get Homeland Security grants
  • Homeland security gets involved with Indiana water conservation
  • LAPD embraces “predictive policing”
  • New GPS rival is hack-proof
  • German internal security service head quits over botched investigation
  • Americans favor Obama to defend against space aliens: poll
  • U.S. Coast Guard creates “protest-free zone” in Alaska oil drilling zone
  • Congress passes measure to enhance Israel security ties
  • Wickr enables encrypted, self-destructing iPhone messages
  • NASA explains Why clocks got an extra second on 30 June
  • Cybercrime disclosures rare despite new SEC rule
  • First nuclear reactor to go back online since Japan disaster met with protests
  • Israeli security fence architect: Why the barrier had to be built
  • DHS allocates nearly $10 million to Jewish nonprofits
  • Turkey deploys troops, tanks to Syrian border
  • Israel fears terror attacks on Syrian border
  • Ontario’s emergency response protocols under review after Elliot Lake disaster
  • Colorado wildfires to raise insurance rates in future years
  • Colorado fires threaten IT businesses
  • Improve your disaster recovery preparedness for hurricane season
  • London 2012 business continuity plans must include protecting information from new risks

Free Subscription

The long view

  • Gain-of-Function Studies Need Stricter Guidance: Researchers

    Researchers and biosecurity specialists are calling on the U.S. government to issue clearer guidance about experiments the government might fund which would make pathogens more transmissible or deadly.

    • Read more
  • BIOMETRICS
  • Border/Immig.
  • Business
  • Cybersecurity
  • Detection
  • Disasters
  • Government
  • Infrastructure
  • Public Safety
  • Public health
  • Regional
  • Sci-Tech
  • Surveillance
  • Terrorism
  • Transportation
  • Water
  • Home
  • About us
  • Subscribe
  • Advertise
  • Contact
  • RSS Feed

Homeland Security News Wire

  • All
  • Regional
    • Africa
    • Americas
    • Asia / Pacific
    • Europe
    • Middle East
  • Water
  • Biometrics
    • Access control
    • E-documents
    • Biometric databases
    • Biometric technologies
    • E-commerce
    • Identity authentication
    • Identity documents
    • National IDs
  • Borders/Immig
    • Border crossings
    • Deportation
    • Border monitoring / protection
    • E-Verify
    • Border security technology
    • Illegal immigration
    • Fencing / barriers
    • Immigration and business
    • Smuggling and contraband
    • U.S. legal employment status
    • Travel documents
    • US VISIT
    • Ultralights, submersibles, tunnels
    • Visa requirements
  • Business
    • Business
    • Companies / JVs / Partnerships
    • Contracts
    • Investment trends
    • M&A
    • Market performance
    • Distribution agreements
    • Government contracts
    • Private sector contracts
    • Strategic partnerships
    • System integrators
    • Venture capital and private equity
  • Cybersecurity
    • Cloud computing
    • Corporate IT security
    • Cybercrime
    • Encryption
    • Firewalls
    • Hackers
    • Information warfare
    • Network security
    • Quantum encryption
    • Social networks
    • VPNs
  • Detection
    • Biological
    • Radiological
    • Chemical
    • Detection - nuclear, biological, chemical
    • Explosive
    • Nuclear
    • Radiological threats
    • Scanning and screening
    • Sensors and Sensor networks
  • Disasters
    • Backup / Storage systems
    • Business continuity
    • Communication interoperability
    • Compliance
    • Corporate security
    • Crisis management
    • Data recovery and management
    • Emergency management systems
    • Emergency Preparedness
    • Natural disasters
    • Risk analysis
    • Resilience / Recovery
    • Terror / Disaster insurance
  • Government
    • Africa code
    • Budget
    • Congress
    • Espionage
    • Government - federal, state, local
    • Information sharing
    • Intelligence
    • International cooperation
    • Laws and regulations
    • Nuclear weapons proliferation
    • Privacy
    • State / Local
    • Terrorism and counterterrorism
  • Infrastructure
    • Alternative energy
    • Bridges, roads, tunnels, canals
    • Chemical plants
    • Construction
    • Dams / Reservoirs
    • Energy
    • Energy policy
    • Energy resources
    • Infrastructure protection
    • Nuclear power
    • Perimeter defense and fencing
    • Power grid and stations
    • Smart grid
    • Water facilities
    • Water Technology / Treatment
  • International
    • African Security
    • Conflict
    • Culture / Religion
    • Failed states
    • Population / Migration
    • Treaties
  • Public health
    • Agroterrorism
    • BioLabs
    • Bioterrorism
    • Epidemics and pandemics
    • Food import controls
    • Food supply chain safety
    • Health standards
    • Infectious disease
    • Viruses and pathogens
    • Public health
    • Vaccines and treatments
  • Public Safety
    • Communication interoperabillity
    • Emergency services
    • Emergency medical services
    • Fire
    • First response
    • IEDs
    • Law Enforcement
    • Law Enforcement Technology
    • Military technology
    • Nonlethal weapons
    • Nuclear weapons
    • Personal protection equipment
    • Police
    • Notification /alert systems
    • Situational awareness
    • Weapons systems
  • Sci-Tech
    • Biotechnology
    • Certification and credentialing
    • Degree programs
    • Computers / software
    • Credentialing
    • Education / training
    • Engineering
    • Environment
    • Materials
    • Nanotechnology
    • National labs
    • Research and Development
    • Robotics
    • Social sciences
    • Technological innovation
  • Sector Reports
    • Biometrics
    • Border & Immigration Control
    • Cybersecurity
    • Detection
    • Emergency Management
    • Infrastructure Protection
    • Law Enforcement
    • World Report
  • Surveillance
    • Asset tracking
    • Eavesdropping
    • FISA
    • Intelligence gathering / analysis
    • Open-source searches
    • RFID technology
    • Search engines
    • Sensors and sensor networks
    • Thermal imaging
    • UAVs / Satellites / Blimps
    • Video analytics
  • Transportation
    • Air cargo / baggage
    • Aviation and Airport
    • Baggage screening
    • Cargo and Containers
    • Ground / Mass transportation
    • HAZMAT transportation
    • Maritime and Ports
    • Transportation Security
 
Advertising & Marketing: advertise@newswirepubs.com
Editorial: editor@newswirepubs.com
General: info@newswirepubs.com
2010-2011 © News Wire Publications, LLC News Wire Publications, LLC
220 Old Country Road | Suite 200 | Mineola | New York | 11501
Permissions and Policies